Skip to content

Research program of Treatment of recurrent spontaneous abortion with traditional Chinese and Western Medicine

Research program of Treatment of recurrent spontaneous abortion with traditional Chinese and Western Medicine

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-17010937
Enrollment
Unknown
Registered
2017-03-21
Start date
2015-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

recurrent spontaneous abortion

Interventions

TCM group :Decoctions of nourishing kidney and promoting blood circulation.
Western medicine group: Duphaston

Sponsors

Longhua hospital Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: (1) the growth period of women, ages 18 to 40 years old, blood beta human chorionic gonadotropin (beta hCG) in the diagnosis of pregnancy and ultrasonic determine see intrauterine pregnancy sac. Gestational age < 12 weeks; (2) with the same partners, the continuous natural abortion twice or more than 2 times; (3) the couple normal karyotype analysis; (4) the female reproductive system without congenital malformations and implement qualitative sex pathological change; (5) anti cardiolipin antibody, closed normal antibodies, intrauterine membrane resistance; (6) to rule out infection factors and harmful substance; (7) sign the informed consent of the patients.

Exclusion criteria

Exclusion criteria: (1) thrombophlebitis, thrombosis disease, or a history of the patients with cerebral apoplexy; (2) to rule out a serious physical illness such as heart, liver, kidney, brain and serious body disease and malignant tumor; (3) out of known allergy to drug ingredients; (4) allergic to Duphaston

Design outcomes

Primary

MeasureTime frame
Uterine accessories ultrasound;maternal and infant's conditions;

Secondary

MeasureTime frame
HCG;Serum P;Serum PRL;TSH;D - dimer;

Countries

China

Contacts

Public ContactLi Ji

Longhua hospital Shanghai University of Traditional Chinese Medicine

drliji@163.com+86 18917763030

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026